Continental Laboratory Products, Inc. v. Medax International, Inc.
This text of 195 F.R.D. 675 (Continental Laboratory Products, Inc. v. Medax International, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ORDER (1) RESOLVING DEFENDANTS’ PROCEDURAL OBJECTIONS TO AFFIDAVITS OF DANIEL M. CISLO AND DR. HAROLD KASSARJIAN; (2) PERMITTING ADDITIONAL BRIEFING ON INHERENT DISTINCTNESS
Before the Court is a motion for summary judgment filed by Defendants Medax International, Inc. and individual Defendants Alma A. Timpson, Jr. and Paul M. Jessop (“Defendants”), seeking judgment against claims for trade dress infringement and unfair competition brought by Plaintiff Continental Laboratory Products, Inc. (“Continental”). The Court has jurisdiction pursuant to 28 U.S.C. §§ 1331 & 1338(a).
The Court is approaching a resolution on the instant motion, and writes this order separately to address two issues: (1) Defendants’ procedural objections to two expert affidavits filed by Continental in opposition to Defendants’ motion for summary judgment, and (2) the impact of a recently decided Supreme Court case, Wal-Mart Stores, Inc. v. Samara Brothers, Inc., 529 U.S. 205, 120 S.Ct. 1339, 146 L.Ed.2d 182 (2000), on the issues presented in this litigation. The Court shall address each of these issues in turn.
A. DEFENDANTS’ OBJECTIONS TO EXPERT AFFIDAVITS
In opposing Defendants’ motion for summary judgment, Continental filed two affida-. vits from expert witnesses Daniel M. Cislo and Dr. Harold Kassarjian. Defendants contend the Court should disregard these experts’ affidavits because Continental failed to previously designate or identify them during discovery. Defendants argue that Continental did not reveal these experts until Continental filed its opposition to the instant motion for summary judgment, and that this untimely disclosure violates the Court’s prior scheduling orders.
Rule 26(a) of the Federal Rules of Civil Procedure requires parties to disclose the identity of any person who may be used as an expert witness. See Fed. R. Civ. P. 26(a)(2)(A). The Rule further provides that “[tjhese disclosures shall be made at the times directed by the court.” See Fed. R. Crv. P. 26(a)(2)(C). Rule 37(c)(1), as amended effective December 1993, provides that if a party fails to make disclosure or to supplement responses as required by Rule 26(a), that party shall not present at trial or in motions any evidence not so disclosed, unless there is “substantial justification” for the failure to disclose or the “failure is harmless.” See Fed. R. Civ. P. 37(c)(1). Generally “[t]he sanction of exclusion is ... automatic and mandatory unless the party to be sanctioned can show that its violation of Rule 26(a) was either justified or harmless.” Finley v. Marathon Oil Co., 75 F.3d 1225, 1230 (7th Cir. 1996). The purpose of these rules is to encourage timely disclosure of expert witnesses and to curb dilatory litigation tactics. See generally 7 James Wm. Moore et al., Moore’s Federal Practice § 37.60[1] (3d ed.1999).
On September 10, 1998 the Court issued a pretrial scheduling order requiring Confinen-' tal to designate and disclose its expert witnesses by December 11, 1998. {See Scheduling Order Regulating Discovery and Other Pretrial Proceedings (Doc. No. 45), at 1:25-26). On December 11, 1998 Continental furnished Defendants with its expert disclosure statement, designating Robert Trout, Ph.D. and Richard P. Meyst. {See Plaintiffs Disclosure of Expert Witnesses, lodged as Ex. 32 to Defs.’ Reply). Continental designated [677]*677Trout to provide testimony concerning damages caused by Defendants’ alleged unfair competition, “including lost profits and price erosion.” (Id. at 2). Continental designated Meyst to provide testimony on “product design,” including “testimony that Continental’s trade dress is nonfunctional and the availability of alternative designs.” (Id.). Continental did not, however, designate Cislo, Kassarijan or any other expert witnesses. Defendants contend the Court should disregard Cislo and Kassarijan’s affidavits because Continental failed to properly disclose them as required by the Court’s September 1998 scheduling order.1
Although the Federal Circuit has ex- ■ elusive appellate jurisdiction over this action, the Court must nonetheless apply regional circuit law, in this case the law of the Ninth Circuit, in determining whether to exclude expert testimony for failure to comply with the September 1998 scheduling order. See, e.g., Trilogy Communications, Inc. v. Times Fiber Communications, Inc., 109 F.3d 739, 744, 42 USPQ2d 1129, 1133 (Fed.Cir.1997). In the Ninth Circuit, “[t]he district court is given broad discretion in supervising the pretrial phase of litigation, and its decisions regarding the preclusive effect of a pretrial order ... will not be disturbed unless they evidence a clear abuse of discretion.” Miller v. Safeco Title Ins. Co., 758 F.2d 364, 369 (9th Cir.1985). For example, the Ninth Circuit has affirmed the exclusion of untimely expert testimony where the plaintiff unjustifiably missed the deadline for disclosing expert witnesses by 20 days and missed the deadline for submitting expert reports by six weeks. Quevedo v. Trans-Pacific Shipping, Inc., 143 F.3d 1255, 1258 (9th Cir.1998) (White, J.) (upholding exclusion of untimely expert testimony submitted by plaintiff in opposition to summary judgment).
Here, Continental’s disclosure of Cislo and Kassarjian is untimely not by 20 days or six weeks — -but by almost one year. Continental. filed its opposition to the instant motion for summary judgment on November 5, 1999, almost 11 months after the expert designation deadline had passed. Continental’s opposition memorandum and its response to Defendants’ evidentiary objections provide no justification for not timely designating these experts by December 11, 1998. Continental never sought to extend the expert designation date and did not seek to introduce the affidavits of Cislo and Kassarijan in any of the four previous motions directed to its trade dress claims.
Continental commenced this action in March 1997 and has had ample time to determine the experts it may need to establish trade dress infringement. Allowing Continental to unexpectedly spring the testimony of two undisclosed experts, over two and a half years after commencement of this action, would unfairly prejudice Defendants. The Court therefore finds that Continental’s failure to provide any justification for the late disclosure of Cislo and Kassarijan, coupled with the unfair prejudice that could flow from considering their testimony, require exclusion under Rule 37(c)(1). The Court SUSTAINS Defendants’ objections to Cislo and Kassarijan and strikes them from the record.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
195 F.R.D. 675, 2000 U.S. Dist. LEXIS 12497, 2000 WL 1224818, Counsel Stack Legal Research, https://law.counselstack.com/opinion/continental-laboratory-products-inc-v-medax-international-inc-casd-2000.